C4 Therapeutics, Inc.
CCCC$4.17▲ 5.18% 24h
C4 Therapeutics, Inc.CCCC$4.17
+$2.07(+98.37%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$406.41M
P/E ratio
—
EPS (diluted)
$-1.27
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$35.95M
Net income
$-104.99M
Net margin
-292.1%
Gross margin
—
Dividends & financials
C4 Therapeutics, Inc. (CCCC) reported revenue of $35.95M and net income of $-104.99M, or $-1.27 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.